This leads to fermentation and gas production, which can cause more burping
Fragrances are a surprising category where sales are up as people take weight loss products
At the 4-month mark, participants taking pramlintide experienced weight loss ranging from 3.449 to 6.1 kg, while the placebo group lost only 2.449 kg
For tirzepatide, 503A (traditional) pharmacies had until February 18, 2025, and 503B (outsourcing) facilities had until March 19, 2025 to stop their GLP-1 production
The FDA has approved multiple therapeutic classes for Crohn's disease management, with treatment selection based on disease severity, location, phenotype (inflammatory, stricturing, or penetrating), and prior treatment response
Maintenance programme and home care prescription initiated to sustain and prevent recurrence